日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The predictive value of intestinal ultrasound for treatment response in inflammatory bowel disease: a systematic review and pooled data analysis

肠道超声对炎症性肠病治疗反应的预测价值:系统评价和汇总数据分析

Vos, Johanna M B W; Teichert, Christoph; De Voogd, Floris A E; Pruijt, Maarten J; Jamaludin, Faridi S; D'Haens, Geert R A M; Benninga, Marc A; Koot, Bart G P; Gecse, Krisztina B

Histopathological Findings of Appendix Specimens in Quiescent Ulcerative Colitis: Correlations With Clinical Outcomes in the ACCURE Trial

静止期溃疡性结肠炎阑尾标本的组织病理学发现:与 ACCURE 试验临床结果的相关性

Visser, Eva; Danielsson, Demy; Heuthorst, Lianne; D'Haens, Geert R; Bemelman, Willem A; Buskens, Christianne J; Mookhoek, Aart

Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes

选择性抑制SIK2/SIK3可重编程髓系细胞中的促炎和抗炎通路,从而改善自身免疫性疾病的预后。

De Vos, Steve; Desroy, Nicolas; Bellaire, Susan J; Fernandes, Anna Pereira; Lavazais, Stéphanie; Merciris, Didier; Delachaume, Carole; Robin-Jagerschmidt, Catherine; Cosson, Adrien; Lazaryan, Angela; Van Osselaer, Nancy; Amantini, David; Peixoto, Christophe; Colli, Maikel L; Van Eeckhoutte, Thomas; Hakonen, Tiina; Constant, Magali; Garcia-Hernandez, Alberto; Barron, Rahul; D'Haens, Geert; Böcher, Wulf O

Etrasimod Treatment Modulates Circulating and Lymph Node-Derived Lymphocytes in Crohn's Disease

依曲莫德治疗可调节克罗恩病患者循环和淋巴结来源的淋巴细胞

Nikolakis, Dimitrios; Pruijt, Maarten J; Verhoeff, Jan; de Voogd, Floris A E; Teichert, Christoph; Ryan, Rathi D; Branquinho, Diogo; Crosby, Catherine; van de Sande, Marleen G H; Grootjans, Joep; D'Haens, Geert R

Colonic biopsy-associated microbial signatures are predictive of response to anti-TNFα biological therapy in Crohn's disease

结肠活检相关的微生物特征可预测克罗恩病患者对TNFα抑制剂生物疗法的反应

Zafeiropoulou, Konstantina; Hageman, Ishtu L; Mu, Tianqi; Davids, Mark; Li Yim, Andrew Y F; Joustra, Vincent W; Hakvoort, Theodorus B M; Satsangi, Jack; Chronas, Konstantinos; Koelink, Pim J; Wildenberg, Manon E; van den Wijngaard, Rene M; D'Haens, Geert R; de Jonge, Wouter J

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease

克罗恩病患者接受静脉注射维多珠单抗维持治疗期间,较高的维多珠单抗清除率与较差的治疗效果相关。

Anjie, Suzanne I; D'Haens, Geert R; Baert, Filip; Bossuyt, Peter; Hoentjen, Frank; Clasquin, Esmé; Molnár, Tamás; Löwenberg, Mark; Vermeire, Séverine; Panetta, J Carl; Dervieux, Thierry

Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis.

黏膜B细胞的扩增和成熟是结肠炎发病机制的促成因素。

Fung Ivan C N, Koelink Pim J, Mulders Lieven G M, Admiraal Iris, Verseijden Caroline, Verhoeff Jan, Wildenberg Manon E, Luo Yi, D'Haens Geert R, Li Yim Andrew Y F, de Jonge Wouter J

One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants

在健康受试者中,一次皮下注射2毫升Mirikizumab与两次皮下注射1毫升Mirikizumab具有生物等效性。

Otani, Yuki; Payne, Christopher D; Loftus, Edward V Jr; D'Haens, Geert; Ben Horin, Shomron; Upadhya K, Abhishek; Todd, Kristin; Pellanda, Paola; Shi, Galen; Zhang, Xin

Utility of T2* and DWI-IVIM to distinguish inflammatory and noninflammatory strictures in Crohn's disease: a prospective cross-sectional cohort study

T2* 和 DWI-IVIM 在区分克罗恩病炎症性和非炎症性狭窄中的应用价值:一项前瞻性横断面队列研究

Beek, Kim Johanna; van Rijn, Kyra; de Voogd, Floris; Wassenaar, Nienke Petronella Maria; Buskens, Christianne; van der Bilt, Jarmila; Bemelman, Willem; D'Haens, Geert Renaat; Gecse, Krisztina Barbara; Horsthuis, Karin; Tielbeek, Jeroen; Mookhoek, Aart; Neefjes-Borst, Andra; Gurney-Champion, Oliver; Stoker, Jaap

Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trial

ABBV-154治疗中重度活动性克罗恩病患者的疗效和安全性:一项2b期随机、双盲、安慰剂对照试验

Reinisch, Walter; Peyrin-Biroulet, Laurent; D'Haens, Geert; Sturm, Andreas; Anderson, Jaclyn K; Messina, Izabella; Arikan, Dilek; Zimmerman-Bennett, Alissa; Parmentier, Julie; Feng, Tian; D'Cunha, Ronilda; Lazar, Andreas; Louis, Edouard